Colgate-Palmolive Company (CL)
NYSE: CL · Real-Time Price · USD
91.81
-0.56 (-0.61%)
Dec 27, 2024, 4:00 PM EST - Market closed
Colgate-Palmolive Company Stock Forecast
Stock Price Forecast
The 19 analysts with 12-month price forecasts for CL stock have an average target of 105.11, with a low estimate of 91 and a high estimate of 122. The average target predicts an increase of 14.49% from the current stock price of 91.81.
Analyst Consensus: Buy
* Price targets were last updated on Oct 28, 2024.
Analyst Ratings
The average analyst rating for CL stock from 20 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 7 | 6 | 6 | 6 |
| Buy | 5 | 5 | 6 | 6 | 6 | 6 |
| Hold | 6 | 6 | 6 | 7 | 7 | 7 |
| Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 19 | 20 | 20 | 20 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Sell Maintains $100 → $92 | Sell | Maintains | $100 → $92 | +0.21% | Oct 28, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $115 → $110 | Strong Buy | Maintains | $115 → $110 | +19.81% | Oct 28, 2024 |
| Stifel | Stifel | Strong Buy → Hold Downgrades $105 → $101 | Strong Buy → Hold | Downgrades | $105 → $101 | +10.01% | Oct 28, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $113 → $114 | Buy | Maintains | $113 → $114 | +24.17% | Oct 11, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $121 | Buy | Initiates | $121 | +31.79% | Sep 24, 2024 |
Financial Forecast
Revenue This Year
20.80B
from 19.46B
Increased by 6.89%
Revenue Next Year
21.41B
from 20.80B
Increased by 2.95%
EPS This Year
3.70
from 2.77
Increased by 33.64%
EPS Next Year
3.97
from 3.70
Increased by 7.25%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 21.3B | 22.2B | 23.3B | |||
| Avg | 20.8B | 21.4B | 22.3B | |||
| Low | 19.7B | 19.9B | 20.7B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 9.3% | 6.9% | 8.6% | |||
| Avg | 6.9% | 3.0% | 4.2% | |||
| Low | 1.2% | -4.3% | -3.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 3.89 | 4.15 | 4.63 | |||
| Avg | 3.70 | 3.97 | 4.31 | |||
| Low | 3.50 | 3.69 | 3.97 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 40.3% | 12.0% | 16.6% | |||
| Avg | 33.6% | 7.3% | 8.4% | |||
| Low | 26.3% | -0.2% | 0.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.